Description: Practitioners can help avert opioid-related overdose deaths by increasing patient retention in buprenorphine treatment. The Michigan Department of Licensing and Regulatory Affairs partnered with researchers from Vital Strategies and Johns Hopkins University to study how practices and clinical protocols affect buprenorphine treatment termination rates. Our study found that high-threshold treatment practices were positively associated with buprenorphine treatment termination. This presentation summarizes our research and describes how LARA's new SUB rules can help reduce treatment termination rates.
Earns: .5 CME Credits
Disclosures:
None of the planners or speakers for this educational event have any relevant financial relationships with ineligible companies to disclose.
Statement of Accreditation
The Michigan State Medical Society (MSMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The MSMS designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Presenter(s):
Valencia Lyle, LARA Contractor
Duration:
31 minutes
Release Date: May 14, 2024
Expiration Date: May 31, 2027